These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8930448)

  • 1. Intravenous immunoglobulin and hepatitis C virus: the Boston episode.
    Schneider LC; Jonas MM; Baron MJ; Mast EF; Alter MJ; Schonberger LB; Lambert S; Coleman P; Bresee JS
    Clin Ther; 1996; 18 Suppl B():108-9. PubMed ID: 8930448
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin and hepatitis C virus: the British episode.
    Healey C; Chapel H
    Clin Ther; 1996; 18 Suppl B():93-5. PubMed ID: 8930446
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of intravenous immunoglobulin with regard to hepatitis C virus.
    Yu MW; Mason BL; Guo ZP; Tankersley DL
    Clin Ther; 1996; 18 Suppl B():71-2. PubMed ID: 8930443
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus infection: clinical aspects and treatment with interferon alfa.
    Jonas MM
    Clin Ther; 1996; 18 Suppl B():110-25. PubMed ID: 8930449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience.
    Björkander J; Fasth A; Widell A
    Clin Ther; 1996; 18 Suppl B():73-82. PubMed ID: 8930444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
    Jonas MM; Baron MJ; Bresee JS; Schneider LC
    Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV and hypogammaglobulinemia.
    Sierra FJ; Gil-Aguado A; Echevarria JM; León P; Martin JC; Lavilla P; Garcia Rodriguez MC; Fontan G
    J Hepatol; 1997 May; 26(5):1158-9. PubMed ID: 9186852
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A; Walker E
    Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C and intravenous immunoglobulin. April 29-30, 1995, Orlando, Florida. Papers from the symposium.
    Clin Ther; 1996; 18 Suppl B():1-139. PubMed ID: 9081773
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis G virus in intravenous immunoglobulin.
    Chen PJ; Kao JH; Chen DS
    Gastroenterology; 1996 Nov; 111(5):1399-400. PubMed ID: 8898661
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus transmission by intravenous immunoglobulin.
    James RC; Mosley JW
    Lancet; 1995 Aug; 346(8971):374; author reply 374-5. PubMed ID: 7542719
    [No Abstract]   [Full Text] [Related]  

  • 12. Gammagard and reported hepatitis C virus episodes.
    Gomperts ED
    Clin Ther; 1996; 18 Suppl B():3-8. PubMed ID: 8930438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain.
    Echevarría JM; León P; Domingo CJ; López JA; Elola C; Madurga M; Salmerón F; Yap PL; Daub J; Simmonds P
    Transfusion; 1996 Aug; 36(8):725-30. PubMed ID: 8780668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C after intravenous immunoglobulin.
    Sewell WA; Mullighan CG; Christie J; Chapel HM
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):466-7. PubMed ID: 9396984
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C virus transmission by intravenous immunoglobulin.
    Yap PL; McOmish F; Webster AD; Hammarstrom L; Smith CI; Bjorkander J; Ochs HD; Fischer SH; Quinti I; Simmonds P
    J Hepatol; 1994 Sep; 21(3):455-60. PubMed ID: 7836718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C transmission associated with intravenous immunoglobulins.
    Yu MW; Mason BL; Guo ZP; Tankersley DL; Nedjar S; Mitchell FD; Biswas RM
    Lancet; 1995 May; 345(8958):1173-4. PubMed ID: 7536874
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C transmission associated with intravenous immunoglobulins.
    Nübling CM; Willkommen H; Löwer J
    Lancet; 1995 May; 345(8958):1174. PubMed ID: 7536875
    [No Abstract]   [Full Text] [Related]  

  • 18. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H
    Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data.
    Yap PL
    Clin Ther; 1996; 18 Suppl B():43-58. PubMed ID: 8930441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France.
    Lefrère JJ; Loiseau P; Martinot-Peignoux M; Mariotti M; Ravera N; Thauvin M; Marcellin P; Janot C
    Transfusion; 1996 May; 36(5):394-7. PubMed ID: 8693501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.